Skip to content

The Application of Metabolomics in Febrile Seizures

The Application of Metabolomics in Febrile Seizures

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106548
Enrollment
Unknown
Registered
2025-07-25
Start date
2025-07-25
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile convulsion

Interventions

The group with fever but without convulsions:None
Febrile seizure group:None

Sponsors

Foshan Maternity & Child Healthcare Hospital,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: 1. Children with FS aged between 6 months and 5 years; 2. The parents of the subjects have agreed that the remaining blood can be used for scientific research; 3. The baseline data of the patients are complete.

Exclusion criteria

Exclusion criteria: Intracranial infection, epilepsy, craniocerebral trauma, electrolyte and water metabolism disorder, genetic metabolic diseases, rheumatic immune diseases, immunodeficiency diseases, tumors, etc.

Design outcomes

Primary

MeasureTime frame
Non-targeted metabolomics;

Countries

China

Contacts

Public ContactTang Haiting

Foshan Maternity & Child Healthcare Hospital,

2515796838@qq.com+86 180 3883 0474

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026